Hi, what are you looking for?
Jewish Business News
Search results for " Erez Vigodman"
Business
The exercising of the underwriters' options brings the total raised by Teva Pharmaceuticals in its current offering to $7.24 billion.
Business
Julius Baer analyst Lilian Montero insists it's illogical for Mylan to remain independent.
Business
– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) Israel-based generic drug maker has entered into an agreement with Venus Remedies to sell anti- cancer drug...
Business
– Adds Significant New Dimension to Teva’s Growing Pain Care Franchise. Peak sales potential of $2-3 billion. – – Teva Pharmaceutical Industries Ltd., (NYSE:TEVA)...
Business
– “Bloomberg” says investors are wondering how long Teva can stay out of the game. “Drugmakers on an acquisition spree have created...